Page last updated: 2024-08-23

piperacillin and amoxicillin-potassium clavulanate combination

piperacillin has been researched along with amoxicillin-potassium clavulanate combination in 39 studies

Research

Studies (39)

TimeframeStudies, this research(%)All Research%
pre-19902 (5.13)18.7374
1990's7 (17.95)18.2507
2000's11 (28.21)29.6817
2010's17 (43.59)24.3611
2020's2 (5.13)2.80

Authors

AuthorsStudies
Baquero, F; Martínez, JL; Pérez-Díaz, JC; Reguera, JA1
Livermore, DM; Seetulsingh, P1
Karahan, M; Kiliç, H1
Cherubin, CE; Eng, RH; Smith, SM1
Aksebzeci, T; Fazli, SA1
Claeys, G; Van den Abeele, AM; Verschraegen, G1
Adams, LB; Harris, EB; Hastings, RC; Prabhakaran, K; Randhawa, B; Williams, DL1
Erwin, ME; Jones, RN; Worth, S1
Grossenbacher, M; Imhof, E; Speich, R; Vogt, M; Zimmerli, W1
Chmela, Z; Hejnar, P; Kolár, M1
Arto, MA; Campos, B; Gracia, O; Gutiérrez, JA; Sanjuán, A1
Maertens, J; Theunissen, K; Van Eldere, J; Verhoef, G1
Olweny, J; Stucki, ZN; Torbert, DP; WaKabongo, M1
Dias, MA; Konefal, SH; McLaughlin, MR; Wadie, GM1
Giordano, P; Herrington, J; Kowalsky, S; Pertel, P; Song, J1
Borzsei, L; Horváth, A; Kocsis, B; Koós, Z; Mintál, T; Nyárády, J1
Bassoul, B; Causse, L; Dareau, S; Delire, V; Eledjam, JJ; Gros, T; Javitary, W1
Choudhri, S; Herrington, J; Malangoni, MA; Pertel, P; Song, J1
de Cueto, M; Hernández, JR; Muniain, MA; Navarro, MD; Pascual, A; Ríos, MJ; Rodríguez-Baño, J; Romero, L1
Choudhri, S; Giordano, P; Lipsky, BA; Song, J1
Docobo, F; Hernández, JR; López-Cerero, L; Morillo, C; Pachón, J; Pascual, A; Picón, E; Rodríguez-Baño, J1
Baquero, F; Cantón, R; Galán, JC; Novais, A; Ripoll, A; Rodríguez-Domínguez, MJ; Turrientes, MC1
Alder, J; Arvis, P; Dryden, M; Gyssens, IC; Hampel, B; Kujath, P; Nathwani, D; Reimnitz, P; Schaper, N1
Bonomo, RA; Perez, F1
Navarro, MD; Pascual, Á; Picón, E; Retamar, P; Rodríguez-Baño, J1
Alder, J; Arvis, P; Dryden, M; Gyssens, IC; Kujath, P; Nathwani, D; Reimnitz, P; Schaper, NC1
Docobo-Pérez, F; Domínguez-Herrera, J; Egea, P; López-Cerero, L; López-Rojas, R; Pachón, J; Pascual, A; Rodríguez-Baño, J1
Antolín, F; Casella, G; Castillo, F; Fernández-Santiago, R; Gómez-Fleitas, M; Herrera, LA; Riaño, M; Rodríguez-Sanjuán, JC1
Singh, HL; Singh, RM1
Hartwich, J; Kurkchubasche, AG; Luks, FI; Muratore, CS; Tracy, TF; Watson-Smith, D; Wills, HE1
Ambeba, EJ; Cooper, JN; Deans, KJ; Lodwick, DL; Mahida, JB; Minneci, PC; Moss, RL; Nacion, KM; Sulkowski, JP1
Freemantle, N; Nisar, S; Ray, D; Shallcross, LJ1
Carroll, K; Romagnoli, M; Simner, PJ; Wang, F; Workneh, M1
Paul, N1
Başaran, S; Bingöl, Z; Çağatay, A; Eraksoy, H; Karabıçak, N; Kılıçaslan, Z; Özsüt, H; Şafak, S; Sarıbuğa, A; Şimşek Yavuz, S; Sutton, DA; Wiederhold, NP1
Allerberger, F; Jesumirhewe, C; Lepuschitz, S; Ruppitsch, W; Springer, B1
Ashraf, T; Darwish, D; Ghazawi, A; Mohsin, J; Pál, T; Petersen, JE; Sonnevend, A1
AlAzmi, A; AlHashem, G; Jamal, W; Khodakhast, FB; Rotimi, VO; Sόki, J1
Adams, R; Agus, A; Barnes, RA; Chau, I; Clarke, M; Coyle, V; Doran, A; Forde, C; Grayson, M; McAuley, DF; McDowell, C; McMullan, R; Plummer, R; Thomas, AL; Wilson, RH1

Trials

7 trial(s) available for piperacillin and amoxicillin-potassium clavulanate combination

ArticleYear
Efficacy, safety, and tolerance of piperacillin/tazobactam compared to co-amoxiclav plus an aminoglycoside in the treatment of severe pneumonia.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:5

    Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Netilmicin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Treatment Outcome

1998
Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection.
    International journal of antimicrobial agents, 2005, Volume: 26, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Tolerance; Female; Fluoroquinolones; Humans; Injections, Intravenous; Male; Middle Aged; Moxifloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Quinolines; Safety; Skin Diseases, Bacterial

2005
Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections.
    Annals of surgery, 2006, Volume: 244, Issue:2

    Topics: Abdominal Abscess; Administration, Oral; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendicitis; Aza Compounds; Bacterial Infections; Cross Infection; Double-Blind Method; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Intestinal Perforation; Male; Middle Aged; Moxifloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Quinolines; Safety; Stomach Rupture; Treatment Outcome

2006
Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:2

    Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Databases, Factual; Diabetic Foot; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Penicillanic Acid; Piperacillin; Quinolines; Tazobactam

2007
A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quinolines; Skin; Skin Diseases, Bacterial

2011
Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study.
    Infection, 2013, Volume: 41, Issue:1

    Topics: Administration, Intravenous; Administration, Oral; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bacteria; Bacterial Infections; Diabetic Foot; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Penicillanic Acid; Piperacillin; Quinolines; Tazobactam; Treatment Outcome

2013
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial.
    Trials, 2020, May-27, Volume: 21, Issue:1

    Topics: Administration, Intravenous; Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Cost-Benefit Analysis; Drug Administration Schedule; Equivalence Trials as Topic; Humans; Meropenem; Multicenter Studies as Topic; Neoplasms; Neutropenia; Piperacillin; Pragmatic Clinical Trials as Topic; Quality of Life; Sepsis; Tazobactam; Treatment Outcome

2020

Other Studies

32 other study(ies) available for piperacillin and amoxicillin-potassium clavulanate combination

ArticleYear
Factors determining resistance to beta-lactam combined with beta-lactamase inhibitors in Escherichia coli.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 27, Issue:5

    Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Cell Membrane Permeability; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

1991
Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin .
    The Journal of antimicrobial chemotherapy, 1991, Volume: 27, Issue:6

    Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Clavulanic Acids; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Lactams; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

1991
[In vitro sensitivity of gram-negative bacteria isolated from urinary tract infections to various antibiotics].
    Mikrobiyoloji bulteni, 1991, Volume: 25, Issue:1

    Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftazidime; Clavulanic Acids; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae; Escherichia coli; Gram-Negative Bacteria; Humans; Klebsiella; Ofloxacin; Piperacillin; Proteus; Pseudomonas; Turkey; Urinary Tract Infections

1991
Beta-lactamase inhibitors and Acinetobacter spp.
    The Journal of antimicrobial chemotherapy, 1990, Volume: 26, Issue:3

    Topics: Acinetobacter; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; beta-Lactamase Inhibitors; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Species Specificity; Sulbactam; Tazobactam

1990
[Susceptibility of clinically-isolated problem pathogenic bacteria to broad spectrum antibiotics].
    Mikrobiyoloji bulteni, 1989, Volume: 23, Issue:4

    Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Ceftriaxone; Clavulanic Acids; Drug Therapy, Combination; Enterobacter; Escherichia coli; Humans; Klebsiella; Netilmicin; Piperacillin; Proteus; Pseudomonas; Staphylococcus

1989
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988, Volume: 7, Issue:1

    Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Corynebacterium; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Norfloxacin; Pefloxacin; Piperacillin; Staphylococcus; Vancomycin

1988
Use of beta-lactam/beta-lactamase-inhibitor combinations as antimycobacterial agents.
    Microbios, 1993, Volume: 76, Issue:309

    Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clavulanic Acids; Drug Therapy, Combination; Mice; Microbial Sensitivity Tests; Mycobacterium; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam

1993
Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Clinical
    Diagnostic microbiology and infectious disease, 1996, Volume: 24, Issue:2

    Topics: Acetamides; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Azithromycin; Clavulanic Acids; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Naphthyridines; Oxazoles; Oxazolidinones; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quality Control; Roxithromycin; Ticarcillin

1996
Double-disk synergy test positivity in Stenotrophomonas maltophilia clinical strains.
    Folia microbiologica, 2004, Volume: 49, Issue:1

    Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Enzyme Inhibitors; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Stenotrophomonas maltophilia; Sulbactam

2004
[Self-limited thrombotic microangiopathy associated with perianal abscess].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2004, Volume: 24 Suppl 3

    Topics: Abscess; Acute Kidney Injury; Adult; Amoxicillin-Potassium Clavulanate Combination; Anal Canal; Debridement; Drug Therapy, Combination; Female; Hemolytic-Uremic Syndrome; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasma; Plasmapheresis; Staphylococcal Infections; Thrombocytopenia

2004
False-positive Aspergillus galactomannan antigen test results.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Jul-15, Volume: 39, Issue:2

    Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Antigens, Fungal; Aspergillus; False Positive Reactions; Galactose; Humans; Male; Mannans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2004
Effect of bovine lactoferrin on the MICs of ampicillin/sulbactam (UNASYN), amoxicillin/clavulanic acid (Augmentin), ticarcillin clavulanate (Timentin), and piperacillin-tazobactam (ZOSYN), against clinical and environmental isolates of motile Aeromonas.
    The Journal of the American Osteopathic Association, 2005, Volume: 105, Issue:1

    Topics: Aeromonas; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Animals; Anti-Bacterial Agents; Cattle; Clavulanic Acids; Lactoferrin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Ticarcillin

2005
Cervical spondylodiscitis from an ingested pin: a case report.
    Journal of pediatric surgery, 2005, Volume: 40, Issue:3

    Topics: Accidents; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Bone Plates; Ceftriaxone; Cervical Vertebrae; Clindamycin; Combined Modality Therapy; Deglutition Disorders; Discitis; Diskectomy; Emergencies; Equipment Contamination; Follow-Up Studies; Foreign Bodies; Humans; Laryngoscopy; Larynx; Male; Neck Pain; Oxacillin; Paresthesia; Penicillanic Acid; Pharynx; Piperacillin; Piperacillin, Tazobactam Drug Combination; Radiography; Recurrence; Retropharyngeal Abscess; Spinal Fusion; Vancomycin; Wounds, Penetrating

2005
Comparative study of antibiotic-containing polymethylmetacrylate capsules and beads.
    Chemotherapy, 2006, Volume: 52, Issue:1

    Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Capsules; Clindamycin; Microspheres; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymethyl Methacrylate

2006
[Postoperative pneumonia: nosocomial, predictable, iatrogenic, preventable or not?].
    Annales francaises d'anesthesie et de reanimation, 2006, Volume: 25, Issue:4

    Topics: Alcoholism; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Carcinoma, Squamous Cell; Ciprofloxacin; Cross Infection; Disease Susceptibility; Fatal Outcome; Humans; Iatrogenic Disease; Immunocompromised Host; Liver Cirrhosis, Alcoholic; Male; Malnutrition; Malpractice; Middle Aged; Mouth; Neck Dissection; Neoplasm Recurrence, Local; Oxygen; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Postoperative Complications; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking; Tongue Neoplasms

2006
Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Dec-01, Volume: 43, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cephalosporins; Cohort Studies; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2006
Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:2

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Microbial Viability; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors

2010
In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10

    Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Clavulanic Acid; DNA, Bacterial; Escherichia coli; Escherichia coli Proteins; Evolution, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Penicillanic Acid; Piperacillin; Plasmids; Selection, Genetic; Tazobactam

2011
Can we really use ß-lactam/ß-lactam inhibitor combinations for the treatment of infections caused by extended-spectrum ß-lactamase-producing bacteria?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Jan-15, Volume: 54, Issue:2

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; Escherichia coli Infections; Female; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2012
β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Jan-15, Volume: 54, Issue:2

    Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamase Inhibitors; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proportional Hazards Models; Prospective Studies; Spain

2012
Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis model.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:5

    Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; beta-Lactamases; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Female; Imipenem; Injections, Intramuscular; Injections, Intraperitoneal; Intraabdominal Infections; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Treatment Outcome

2013
How long is antibiotic therapy necessary after urgent cholecystectomy for acute cholecystitis?
    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2013, Volume: 17, Issue:11

    Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cholecystectomy; Cholecystitis, Acute; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Care; Prospective Studies; Risk Assessment; Surgical Wound Infection; Time Factors

2013
Comparative evaluation of six phenotypic methods for detecting extended-spectrum beta-lactamase-producing Enterobacteriaceae.
    Journal of infection in developing countries, 2014, Apr-15, Volume: 8, Issue:4

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Enterobacteriaceae; False Negative Reactions; False Positive Reactions; Female; Humans; India; Male; Microbial Sensitivity Tests; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests

2014
Nonoperative treatment of acute appendicitis in children: A feasibility study.
    Journal of pediatric surgery, 2016, Volume: 51, Issue:1

    Topics: Acute Disease; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendectomy; Appendicitis; beta-Lactamase Inhibitors; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quality of Life; Recurrence; Treatment Failure

2016
Effectiveness of Patient Choice in Nonoperative vs Surgical Management of Pediatric Uncomplicated Acute Appendicitis.
    JAMA surgery, 2016, 05-01, Volume: 151, Issue:5

    Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendectomy; Appendicitis; Child; Ciprofloxacin; Family; Female; Health Care Costs; Humans; Laparoscopy; Male; Metronidazole; Patient Participation; Patient Preference; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome

2016
A cross-sectional study of blood cultures and antibiotic use in patients admitted from the Emergency Department: missed opportunities for antimicrobial stewardship.
    BMC infectious diseases, 2016, Apr-18, Volume: 16

    Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Bacteremia; Cross-Sectional Studies; Emergency Service, Hospital; Female; Hospitals, University; Humans; Male; Microbiological Techniques; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam

2016
Bypass graft infection and bacteremia caused by Anaerostipes caccae: First report of human infection caused by a recently described gut anaerobe.
    Anaerobe, 2016, Volume: 42

    Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anastomosis, Surgical; Anti-Bacterial Agents; beta-Lactams; Blood Culture; Clostridiales; Ertapenem; Female; Gram-Positive Bacterial Infections; Humans; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Surgical Wound Infection; Vancomycin

2016
The U.S. Food and Drug Administration announcement suggests the need to revisit guidelines for antibiotic use after EUS-FNA.
    Gastrointestinal endoscopy, 2016, Volume: 84, Issue:5

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Care; Practice Guidelines as Topic; United States; United States Food and Drug Administration

2016
[A case of coccidioidomycosis in Turkey imported from the United States of America].
    Mikrobiyoloji bulteni, 2017, Volume: 51, Issue:2

    Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Antifungal Agents; Arizona; Coccidioides; Coccidioidomycosis; Fluconazole; Humans; Itraconazole; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pleura; Recurrence; Spores, Fungal; Travel; Turkey

2017
Carbapenemase-Producing Enterobacteriaceae Isolates from Edo State, Nigeria.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Cefotaxime; Ceftazidime; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae Infections; Ertapenem; Fluoroquinolones; Humans; Nigeria; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2017
Plasmid-Mediated Colistin Resistance Gene mcr-1 in an Escherichia coli ST10 Bloodstream Isolate in the Sultanate of Oman.
    Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:3

    Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Humans; Membrane Proteins; Microbial Sensitivity Tests; Oman; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Protein Isoforms; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination

2018
Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait.
    BMC microbiology, 2020, 01-15, Volume: 20, Issue:1

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Toxins; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Clindamycin; Drug Resistance, Bacterial; Feces; Female; Humans; Imipenem; Kuwait; Male; Meropenem; Metronidazole; Microbial Sensitivity Tests; Piperacillin; Prevalence; Prospective Studies; Respiratory Tract Infections; Sepsis; Tigecycline; Wound Infection

2020